Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression
- 14 March 2007
- journal article
- review article
- Published by Wiley in Cancer Science
- Vol. 98 (5) , 629-635
- https://doi.org/10.1111/j.1349-7006.2007.00449.x
Abstract
Cyclin D1 binds to the Cdk4 and Cdk6 to form a pRB kinase. Upon phosphorylation, pRB loses its repressive activity for the E2F transcription factor, which then activates transcription of several genes required for the transition from the G1- to S-phase and for DNA replication. The cyclin D1 gene is rearranged and overexpressed in centrocytic lymphomas and parathyroid tumors and it is amplified and/or overexpressed in a major fraction of human tumors of various types of cancer. Ectopic overexpression of cyclin D1 in fibroblast cultures shortens the G1 phase of the cell cycle. Furthermore, it has been demonstrated that introduction of an antisense cyclin D1 into a human carcinoma cell line, in which the cyclin D1 gene is amplified and overexpressed, causes reversion of the malignant phenotype. Thus, increased expression of cyclin D1 can play a critical role in tumor development and in maintenance of the malignant phenotype. However, it is insufficient to confer transformed properties on primary or established fibroblasts. In this review, we summarize the role of cyclin D1 on tumor development and malignant transformation. In addition, our chemical biology study to understand the regulatory mechanism of cyclin D1 transcription is also reviewed.This publication has 40 references indexed in Scilit:
- Retinoic acid induced repression of AP-1 activity is mediated by protein phosphatase 2A in ovarian carcinoma cellsJournal of Cellular Biochemistry, 2005
- RASSF1A Suppresses the c-Jun-NH2-Kinase Pathway and Inhibits Cell Cycle ProgressionCancer Research, 2005
- Estrogen-induced proliferation of normal endometrial glandular cells is initiated by transcriptional activation of cyclin D1 via binding of c-Jun to an AP-1 sequenceOncogene, 2004
- Regulation of FGF receptor-2 expression by transcription factor E2F-1Oncogene, 2003
- Bcl-2 Inhibits Calcineurin-mediated Fas Ligand Expression in Antitumor Drug-treated Baby Hamster Kidney CellsJapanese Journal of Cancer Research, 2000
- Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum.Journal of Clinical Investigation, 1998
- Effects of Cyclin D1 Overexpression on G1 Progression-Related EventsExperimental Cell Research, 1997
- Sensitivity to cis-diamminedichloroplatinum in human cancer cells is related to expression of cyclin D1 but not C-RAF-1 proteinInternational Journal of Cancer, 1996
- AnnouncementsCell, 1993
- The receptor encoded by the human C‐MET oncogene is expressed in hepatocytes, epithelial cells and solid tumorsInternational Journal of Cancer, 1991